Mamaroneck, NY, United States of America

Jai-Tung Huang


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Jai-Tung Huang and His Contributions to Cancer Research

Introduction: Jai-Tung Huang, based in Mamaroneck, NY, is an inventor recognized for his notable contributions to the field of cancer research. With a unique patent focusing on substituted 1-phenylnaphthalenes, Huang's work emphasizes innovative solutions for pharmaceutical applications.

Latest Patents: Huang holds a significant patent relating to substituted 1-phenylnaphthalenes. This patent details compounds with a specific structural composition, where each substituent can vary, including hydrogen, hydroxyl, methoxy, methyl, carboxaldehyde, or phenylformazen groups. Additionally, this patent encompasses a novel synthesis process for these compounds, offering critical intermediate compounds beneficial in various applications. The invention extends to pharmaceutical compositions that contain a therapeutically effective amount of the claimed compounds alongside an acceptable carrier. A key highlight of this invention is its potential for spermicidal applications and its role in inhibiting or slowing the proliferation of cancer cells.

Career Highlights: Huang is affiliated with the Sloan Kettering Institute for Cancer Research, where he contributes to groundbreaking advancements in cancer treatment methodologies. His patent reflects a deep understanding of chemical structures and their biological implications, showcasing his dedication to enhancing therapeutic options.

Collaborations: During his career, Huang has worked alongside esteemed colleagues such as Kyoichi A Watanabe and Tsann-Long Su. These collaborations emphasize the importance of teamwork in the innovation process, combining expertise from different areas to drive significant research breakthroughs.

Conclusion: Jai-Tung Huang is a prime example of how innovations in chemical compounds can lead to important advancements in cancer treatment. His patent on substituted 1-phenylnaphthalenes represents a crucial step forward in developing effective pharmaceutical solutions. Through his work at the Sloan Kettering Institute for Cancer Research and partnerships with other experts, Huang continues to inspire progress in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…